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Endoglin (CD105) expression differentiates
between aseptic loosening and periprosthetic
joint infection after total joint arthroplasty
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Abstract
The differentiation between aseptic loosening and periprosthetic joint infection (PJI) after total joint arthroplasty
is essential for successful therapy. A better understanding of pathogenesis of aseptic loosening and PJI may help
to prevent or treat these complications. Previous investigations revealed an increased vascularization in the
periprosthetic membrane in cases of PJI via PET signals. Based on these findings our hypothesis was that PJI is
associated with an increased neovascularization in the periprosthetic membrane.
Tissue samples from periprosthetic membranes of the bone-implant interface were investigated histologically for
inflammation, wear particles, vascularization and fibrosis. To identify vascular structures antibodies against CD 31,
CD 34, factor VIII and CD 105 (endoglin) were applied for immunohistochemical investigations. According to a
consensus classification of Morawietz the tissue samples were divided into four types: type I (wear particle induced
type, n = 11), type II (infectious type, n = 7), type III (combined type, n = 7) and type IV (indeterminate type, n = 7).
Patients with PJI (type II) showed a pronounced infiltration of neutrophil granulocytes in the periprosthetic
membrane and an enhanced neovascularization indicated by positive immunoreaction with antibodies against CD
105 (endoglin). Tissue samples classified as type I, type III and type IV showed significantly less immune reaction for
CD 105.
In cases of aseptic loosening and PJI vascularization is found in different expression in periprosthetic membranes.
However, in aseptic loosening, there is nearly no neovascularization with CD 105-positive immune reaction.
Therefore, endoglin (CD 105) expression allows for differentiation between aseptic loosening and PJI.
Keywords: Endoglin; Aseptic loosening; Periprosthetic joint infection; Histopathology; Total joint arthroplasty;
Periprosthetic membrane
Introduction
The demographic change in our society yielded in a more
frequent need of endoprostheses. Furthermore, total joint
arthroplasties due to arthrosis become more and more
common at younger ages as there is a progressive inci-
dence of obesity in society. In Germany, around 150,000
total hip arthroplasties are implanted each year and
approximately 1.3 million worldwide (Berry et al. 2000;
Katzer and Löhr 2003). 10 years after implantation endo-
prostheses survivorship rates of 88-95% in total hip re-
placements and 93% in total knee arthroplasties could be
proven (Argenson et al. 2013; Allami et al. 2006). After 15
years implant survival rates of only 58-62% in total hip
arthroplasties and 79% in total knee replacements were
described (Mäkelä et al. 2011; Newman et al. 2009). The
most common reasons for failure are aseptic loosening
and periprosthetic joint infection (PJI) (Lima et al. 2013;
Jiang et al. 2013). The differentiation between both com-
plications remains a key challenge in orthopedic surgery
as the treatment of aseptic loosening is completely differ-
ent to the treatment of PJI (Ellenrieder et al. 2011).
So far, there is no single accepted diagnostic tool to
differentiate between aseptic loosening and PJI. Various
diagnostic tests have been proposed and current recom-
mendations are based on several pre-, intra-, and post-
operative tests (Miyamae et al. 2013; Sendi and
Zimmerli 2012).
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Systemic inflammation markers such as erythrocyte
sedimentation rate (ESR), C-reactive protein (CRP)
serum level and white blood-cell count play a substantial
role in the differentiation between aseptic loosening
and PJI, but they are not consistently reliable as they
are highly sensitive but less specific (Parvizi et al. 2011;
Costa et al. 2012). Cytological investigations of joint
aspirations are suggestive for a PJI with a leukocyte
count greater than 1,700 to 3,000 leukocytes per ml
and with an amount of more than 60% neutrophils in
the synovial fluid (Mason et al. 2013; Dinneen et al.
2013). Results of microbiologic examinations of joint
aspirations can yield false-negative results in 12%
(Parvizi et al. 2008).
Microbiological cultures and histopathological examin-
ation of the periprosthetic membrane of the bone-
implant-interface are crucial procedures to differentiate
between aseptic loosening and PJI (Larsen et al. 2012).
Intraoperative cultures show a broad range of sensitivity
(12-100%) and specifity (81-100%) which is caused by
different incubation times, choice of media as well as
sample contamination (Krukemeyer 2009).
Histopathological examinations of the periprosthetic
membrane proved a valid diagnostic tool with a high
sensitivity and specifity to detect a PJI. A consensus clas-
sification published by Morawietz et al. (2006) allows the
differentiation of four types of loosening membranes
(type I (wear particle-induced type), type II (infectious
type), type III (combined type) and type IV (indetermin-
ate type)) with a high accuracy (0.94) in identification of
PJI.
In conclusion, none of these tests is 100% reliable. False-
positive or negative results could lead to a misdiagnosis
with crucial consequences for the treatment. Conse-
quently, there is a need for further research and develop-
ment into new methods aimed at improving diagnostic
accuracy.
In this context, previous investigations revealed in-
creased vascularization in periprosthetic membranes via
PET signals (Mumme et al. 2003a, 2005, 2003b, Reinartz
et al. 2005; Kisielinski et al. 2003). Concurrent, there is
an intensive expression of endoglin (CD105) during
angiogenesis, especially angioneogenesis in wound heal-
ing and inflammation (Torsney et al. 2002). Endoglin is
a homodimer transmembrane protein. Its expression is
regulated by hypoxia and by binding of TGF-β to endo-
thelium cells offering receptors for TGF-β1 and β3. In
contrast to other vascular markers (factor VIII, etc)
endoglin only stains immature, newly formed vessels
(Cheifetz et al. 1992).
The examination of angiogenesis in the periprosthetic
membrane could be a helpful tool to differentiate be-
tween aseptic loosening and PJI. So far, a study that ex-
amines the expression of endoglin in periprosthetic
membranes has not been described. This study should
create more understanding of the pathogenesis of aseptic
loosening and PJI by investigating angiogenesis histologi-
cally and immunohistochemically in accordance to the
consensus classification of Morawietz. Our hypothesis
was that PJI is associated with an increased neovasculari-
zation in the periprosthetic membrane and endoglin is a
helpful biomarker to differentiate between aseptic loos-
ening and PJI.
Materials and methods
Patient population
In this study, 32 consecutive patients were included who
underwent revision surgery due to aseptic loosening or
PJI after total hip or knee arthroplasty: 29 with total hip
arthroplasties and 3 with total knee arthroplasties. Used
materials were polyethylene (PE) and ceramic. 17 pa-
tients were male with an average age of 65.4 (48-78)
years and 15 female with an average age of 69.5 (49-84)
years. In 6 cases one or more revision surgeries have
been done before. The mean duration from primary
arthroplasty to revision surgery was 12.0 years in type I
(4-23 years), 4.3 years in type II (1-12 years), 10.8 years in
type III (2-15 years) and 8.6 years in type IV (1-21 years).
Preoperatively the laboratory inflammation marker CRP
was determined. In 16 out of 32 cases FDG-PET investiga-
tions were done beforehand. Indications for PET investi-
gations were suspicion of septic or aseptic loosening of
total hip arthroplasties and a time period of at least 12
months postoperatively. PET investigations were not done
in cases of highly septic patients with urgent surgery in-
dication. Out of those 16 cases type I was represented
with 7/11, type II with 4/7, type III with 4/7 and type
IV with 1/7. In 14 cases microbiological examinations
were performed.
Pathological examination
All samples were taken from periprosthetic membranes
from the bone-implant-interface during revision surgery
in cases of aseptic loosening or PJI. Formalin-fixed and
paraffin-embedded material was stained by hematoxylin
and eosin for routine procedures. Inflammation, foreign-
body reaction, neutrophil granulocytes, lymphocytes, mac-
rophages, foreign-body giant cells, fibrosis, vascularization
and wear debris were evaluated semi-quantitatively in a
score system from 0-3 (0 = not existing, 1 = slightly dis-
tinctive, 2 =moderately distinctive, 3 = highly distinctive)
in the entire specimen (400× magnification). Tissue sam-
ples were classified into the different types due to histo-
logical criteria.
Immunohistochemical investigations
Immunohistochemical investigations were performed on
paraffin sections. Antigen retrieval was done with citrate
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buffer at ph 6.0 in a cooking pot. Endogenous peroxidase
was blocked with hydrogen peroxidase. For visualization
the EnVision™ system (Dako) was applied which uses a
streptavidin-biotin polymer conjugated secondary anti-
body with DAB (diaminobenzidine), both per Dako’s in-
structions. Antibodies against CD 31 (dilution: 1:500;
DAKO, Hamburg, Germany) and CD 34 (dilution: 1:200;
DAKO, Hamburg, Germany) which stain mature as well
as immature vessels were used to illustrate the whole of
all vessels. Factor VIII (dilution: 1:300; DAKO, Hamburg,
Germany) was applied to mark mature vessel endothe-
lium and show pre-existing vessels. In contrast endoglin
(CD 105) (dilution: 1:200; DAKO, Hamburg, Germany)
only stains immature which means newly formed vessels.
Positive and negative controls were performed. Accord-
ing to Dako’s instructions positive controls of endoglin
(CD 105) were done with tissue samples of lymph nodes.
The entire immunohistochemical specimens were exam-
ined in 400× magnification with the same semi-quantitative
score system used for evaluation in hematoxylin and eosin
staining.
Statistical analysis
For statistical analysis the program SAS (Version 9.2,
Institute Inc., Cary, NC, USA) was used. Median, mini-
mum, maximum, mean value, Kruskal-Wallis test, Wilcoxon
test, Spearman’s correlation coefficient and weighted
kappa were performed. The Kruskal-Wallis test was used
to compare group 1, 2, 3 and 4. In case of a significant p
calculated with the Kruskal-Wallis test pair comparisons
were performed with the help of the Wilcoxon test. All
tests were performed two-sided. The evaluation was done
exploratory: this means all p values <0.05 were considered
as significant.
Results
Clinical information
1. Relationship of CRP and consensus classification
The laboratory inflammation marker CRP is in
normal range in the majority of patients with type I
(8/11) and type III loosening (4/7) (elevated specimens:
type I: 12-143 mg/l; type III: 30-130 mg/l). CRP
elevations can be proven in 7/7 patients with
type II loosening (30-164 mg/l) and 5/7 with type IV
loosening (6-217 mg/l). There are no false-negative
results concerning elevation of CRP and TEP
loosening of the infectious type. Including type III
loosening to the group of PJI 4/7 CRP values are
false-negative. In the group of aseptic loosening
(type I and type IV) there were 8 false-positive results.
Overall CRP shows a sensitivity of 71%and a specifity
of 56%. Concerning type I and type IV loosening
sensitivities of 73%and 29%are proven. Regarding
type II and type III loosening specifities of 73%and
43%are verified.
2. Microbiological analyses
7 out of 14 microbiological examinations were
positive (1/2 in type I, 3/4 in type II, 2/5 in type III,
1/3 in type IV). False-positive results in type I
and type IV might be due to contamination.
False-negative test results can be caused by
inadequate incubation time, inappropriate choice
of media and antimicrobial therapy.
3. FDG-PET
3/4 PET investigations in cases of type II loosening
showed signs of inflammation (sensitivity 75%). 7/7
PET investigations in type I, 4/4 in type III and 1/1
in type IV were negative concerning signs of
inflammation. A previous FDG-PET investigation
proved a sensitivity of 94%, a specifity of 95% and an
accuracy of 95% in discriminating between infection
and loosening (Reinartz et al. 2005).
Light microscopy
Tissue samples of the periprosthetic membrane of the
bone-implant-interface of all patients were investigated
lightmicroscopically and immunohistochemically. The
specimens show periarticular tissue with synovia and
subsynovial structures, fat as well as connective tissue with
vessels and nerval fascicles. Some show fibrosis. In diver-
ging degree inflammation cells can be found. Depending on
the level of tissue reaction, inflammation and the amount
of wear debris they are categorized using a categorization
developed by Morawietz et al. (2006). Furthermore, wear
particles were classified by a particle algorhythm published
by Krenn et al. (2014).
The periprosthetic membrane of the wear particle-
induced type (type I, n = 11) as shown in Figure 1a is
characterized by macrophages and foreign-body giant
cells. Some show fibrosis. There are small wear particles
in macrophages and big particles incorporated in multi-
nuclear giant cells. Wear debris is displayed birefringent
in polarized light. Lymphocytes are rarely found.
There are no granulocytes in the periprosthetic mem-
brane after semiquantitative evaluation of the examined
tissue samples (mean value 0.0, standard deviation 0.0).
Lymphocytes are expressed with a score of 0.73 (standard
deviation 0.47), macrophages with a score of 2.91 (standard
deviation 0.30), foreign-body giant cells with a score of
2.64 (standard deviation 0.50), vascularization with a score
of 1.0 (standard deviation 0.0), fibrosis with a score of 2.09
(standard deviation 1.30) and wear debris (mainly macro-
particles of polyethylene (PE) and bone cement (PMMA),
no non-implant material, few necrosis, scattered lympho-
cytes) with a score of 2.18 (standard deviation 0.75).
The periprosthetic membrane of the infectious type (type
II, n = 7) which is indicated in Figure 1b is characterized
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by a granulation tissue consisting of capillary proliferation,
fibroblasts and neutrophil granulocytes.
Granulocytes are evaluated with a score of 2.43 (stand-
ard deviation 0.53), lymphocytes with a score of 1.43
(standard deviation 0.79), macrophages with a score of
2.43 (standard deviation 0.53), foreign-body giant cells with
a score of 1.29 (standard deviation 0.95), vascularization
with a score of 2.71 (standard deviation 0.49), fibrosis with
a score of 2.43 (standard deviation 0.79) and wear debris
(mainly microparticles of PE, bone fragments, no necrosis,
1/7 with extensive lymphocyte infiltration) with score of
1.57 (standard deviation 1.27).
The periprosthetic membrane of the combined type
(type III, n = 7) is demonstrated in Figure 1c. It consists
in equal parts of granulocyte dominated granulation
tissue of the infectious type and of macrophage and
foreign-body giant cell dominated wear particle-induced
type.
Granulocytes are expressed with a score of 1.29 (stand-
ard deviation 0.49), lymphocytes with a sore of 1.71 (stand-
ard deviation 0.95), macrophages with a score of 2.71
(standard deviation 0.49), foreign-body giant cells with a
score of 1.57 (standard deviation 0.79), vascularization with
a score of 1.29 (standard deviation 0.49), fibrosis with a
score of 1.43 (standard deviation 0.98) and wear debris
(mainly macroparticles of PE and PMMA, bone fragments,
few necrosis, 1/7 with extensive lymphocyte infiltration)
with a score of 2.0 (standard deviation 0.82).
The periprosthetic membrane of the indeterminate type
(type IV, n = 7) as displayed in Figure 1d is characterized
by a membrane that consists of cell-poor connective
tissues bordered by a thin margin of fibrin with fibro-
blasts and macrophages. A few neutrophil granulocytes
are localized in this margin of fibrin. Wear particles are
hardly found.
Granulocytes are evaluated with a score of 0.71 (stand-
ard deviation 0.49), lymphocytes with a score of 2.86
(standard deviation 0.38), macrophages with a score of
1.86 (standard deviation 0.38), foreign-body giant cells with
a score of 0.29 (standard deviation 0.49), vascularization
with a score of 1.71 (standard deviation 0.49), fibrosis
with a score of 2.29 (standard deviation 0.49) and wear
debris (mainly microparticles of PE, bone fragments, no
necrosis, extensive lymphocyte infiltration) with a score of
1.14 (standard deviation 0.69).
Immunohistochemistry
Subsequent to the findings in light microscopy we per-
formed immunohistochemical investigations to compare
the amount of newly formed vessels, pre-existing vessels
and vessels in general. Both CD 31 and CD 34 were used
as pan-endothelium cell makers. They visualize a highly
distinctive vascularization in type II (7/7 tissue samples
express CD 31 and CD 34 highly distinctive (mean value
3.0, standard deviation 0.0)), a slightly to moderately dis-
tinctive vascularization in type I (mean values: CD 31:
Figure 1 a-d Overview of all types of periprosthetic membranes in H & E staining. Magnification: 200x. a Type I (wear particle-induced type)
with wear debris (marked with thin arrow) (macro-particular PMMA in hollows of PE particles, no non-implant material, no necrosis, no
lymphocytary infiltration) and surrounding foreign-body reaction with macrophages (marked with thick arrow) and foreign-body giant cells.
b Type II (infectious type) with high density of vessels and granulocyte infiltration (marked with arrow). c Type III (combined type) showing
characteristics of the wear particle-induced type and infectious type, less macrophages (thick arrow) and granulocytes (thin arrow). d Type IV
(indeterminate type) with connective tissue, fibrocytes and fibroblasts (marked with arrow); no inflammatory cells.
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1.45, CD 34: 1.91, standard deviations: CD 31: 0.52, CD
34: 0.30) and a moderately distinctive vascularization in
type III and IV (mean values: CD 31 in type III: 1.71, CD
34 in type III: 2.00; CD 31 in type IV: 2.00, CD 34 in type
IV: 2.00, standard deviations: CD 31 in type III: 0.76, CD
34 in type III: 0.58; CD 31 in type IV: 0.58, CD 34 in type
IV: 0.58). These results are displayed in Figure 2.
Factor VIII pointes out a moderate distinctive level of
pre-existing vessels in all types (mean values: type I: 1.64,
type II: 1.86, type III: 1.29, type IV: 2.14, standard devia-
tions: type I: 0.50, type II: 0.38, type III: 1.25, type IV: 0.38)
which is shown in Figure 2.
Figure 3a-d illustrates an immunohistochemical cyto-
plastmatic staining of endothelial cells of newly formed
vessels with CD 105 in periprosthetic membranes. Those
newly formed vessels can be proven in areas of active
inflammation – primarily with an extensive density of gran-
ulocytes (see Figure 4). CD 105-positive vascularization
is highly distinctive in type II (mean value 3.0, stand-
ard deviation 0.0) and slightly distinctive in type III
(mean value 1.0, standard deviation 0.58). CD 105 is
not expressed in type I (mean value 0.0, standard de-
viation 0.0) and slightly in type IV membranes (mean
value 0.43, standard deviation 0.79).
Statistical analysis
The degree of CD 31, CD 34 and CD 105 is expressed
more in type II than in the other types. After statistical
analysis the immunohistochemical impression can be
underlined statistically (CD 31: p = 0.0006, CD 34: p =
0.0003, CD 105 p < 0.0001). CD 105 is also expressed sig-
nificantly more in type III in comparison to type I and IV
(p < 0.0001).
Spearman’s coefficient of correlation (CC) emphasizes
that expression of granulocytes and CD 105 are accom-
panied by each other (CC = 0.83).
Essentials
Light microscopy proves the existence of inflammatory
cells, fibrosis and vascular proliferation in different ex-
pression in all types of periprosthetic membranes. But
the highest degree of inflammation and newly formed ves-
sels can be found in the infectious type (type II). Fibrosis
is found moderately expressed in the wear particle-
induced type (type I), infectious type (type II) and in-
determinate type (type IV) and slightly expressed in the
combined type (type III). Histological and immunohisto-
chemical investigations demonstrate a floride inflamma-
tion process accompanied by neovascularization is
predominantly found in PJI (type II) with a significant ex-
pression of endoglin (CD 105).
Discussion
The correct identification of a periprosthetic joint infec-
tion after total hip or knee arthroplasty is often difficult
as the clinical symptoms often resemble those of aseptic
Figure 2 Immunohistochemical analysis concerning vascularization in periprosthetic membranes (type I-IV). Degree of expression: 0-3.
Vascular markers: CD 31, CD 34, CD 105 (endoglin), factor VIII. CD 105 (endoglin) demonstrates newly formed vessels and is expressed significantly
more in cases of PJI (type II) (p < 0.0001).
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loosening. A false-positive diagnosis of PJI could lead to
an unnecessary two-stage exchange (girdlestone-situ-
ation) or a cemented revision (one-stage exchange). On
the other hand a misdiagnosis of PJI would result in a
one-stage revision without appropriate treatment, most
likely resulting in persisting infection and early implant
failure (Parvizi et al 2010). In cases of clinical signs of
PJI treatment should be initiated within the first 48
hours. Otherwise probabilities of treatment failure rise
significantly (Brandt et al. 1997; Hsieh et al. 2009). There
are a lot of studies attempting to identify the best com-
bination of diagnostic procedures predicting PJI. The
current literature has highlighted the need of further
research in this field (Miyamae et al 2013; Sendi and
Zimmerli 2012).
The hypothesis of our study was that there is an in-
creased vascularization in periprosthetic membranes dur-
ing PJI in contrast to aseptic loosening of total hip or knee
arthroplasty. As previous investigations proved increased
vascularization in periprosthetic membranes via PET sig-
nals (Mumme et al. 2003a, 2005, 2003b; Reinartz et al.
2005; Kisielinski et al. 2003), this study should create
more understanding of both complications by investi-
gating angiogenesis histologically and immunohistochemi-
cally. Guo et al. (2006) describe a positive correlation
between PET-signals and detection of endoglin-positive
newly formed vessels in lung adenocarcinomas. Further-
more, it is well known that there is an increased expression
of endoglin during angiogenesis, especially angioneogen-
esis in wound healing and inflammation (Torsney et al.
2002). A study that examines the expression of endoglin
in periprosthetic membranes of loosened prostheses has
not been described yet.
This study investigated tissue samples of the peripros-
thetic membrane of the bone-implant-interface of 32 pa-
tients. Signs of chronic inflammation are found in all
types of membranes. A foreign-body reaction is predom-
inantly found in type I membranes (wear particle-induced
Figure 3 Immunohistochemical staining with CD 105 of all types of periprosthetic membranes. Magnification: 100x. a Type I (wear particle
induced type) without proof of CD 105-positive endothelium. b Type II (infectious type) with high amount of CD 105-positive endothelium. c Type III
(combined type) with slightly distinctive proof of CD 105. d Type IV (indeterminate type) without proof of CD 105.
Figure 4 Immunohistochemical staining with CD 105 in two high power fields of type II (infectious type) loosening. Magnification: 400x.
CD 105 stains vessel endothelium which is surrounded by a highly density of inflammatory cell infiltration.
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type), whereas a floride inflammation process led by neu-
trophils is found in type II membranes (infectious type).
Fibrosis can be detected in all types of membranes and is
proven in most specimens. These results were represented
in Morawietz’ consensus classification (2006).
Vascularization of small and large vessels proven by
CD 31 and CD 34 are found in all types. But the highest
density of vessels is proven in type II (infectious type). In-
creased vascularization in PJI was also described by Pessler
et al. (2008). To characterize vascularization more detailed
we investigated the vascular profile with the help of anti-
bodies against pre-existing vessels (factor VIII) and newly
formed vessels (endoglin (CD 105)). It could be verified
that type II (infectious type) membranes do not show more
pre-existing vessels but significantly more newly formed
vessels. These newly formed vessels can be proven by
endoglin (CD 105). Periprosthetic membranes of type III
loosening represent a chronic PJI in comparison to the ex-
tended inflammatory infiltrate in our collective of type II
membranes. Granulocytes and endoglin are expressed
significantly less in comparison to type II loosening, but
significantly more in comparison to type I and type IV
loosening. Thus, endoglin allows differentiating between
aseptic loosening and PJI. Our study underlines the results
of studies by Mumme et al. who proved increased cell in-
filtration and vascularization in PJI by FDG-PET (Mumme
et al. 2003a, 2005, 2003b; Reinartz et al. 2005). The role of
endoglin in inflammatory processes was also described by
Rossi et al. (2013). Immunohistochemical detection of
endoglin-positive angiogenesis was demonstrated in speci-
mens of patients with lung cancer by Guo et al. (2006)
and Takase et al. (2010).
In addition, a correlation between neutrophil granulo-
cytes and endoglin (CD 105) can be shown. Pessler et al.
(2008) described that infiltration of granulocytes and neo-
vascularization correlate with each other in chronic septic
arthritis as well as in septic total arthroplasties. Neutrophil
granulocytes produce cytokines in the process of neovascu-
larization (Vågesjö et al. 2012). In our study a correlation
between granulocytes and neovascularization could be
proven in acute phases of infection (type II membranes) as
well as in chronic infections (type III membranes).
Diagnostic synovial biopsies in periprosthetic loosening
are a clinically applied diagnostic tool. Its high diagnostic
value was described by Fink et al. (2013). We could dem-
onstrate that immunohistochemical investigations of the
periprosthetic membrane with endoglin can support the
differentiation between aseptic loosening and PJI. Patients
with PJI (periprosthetic membrane of the infectious type)
show a pronounced infiltration of neutrophil granulocytes
in the periprosthetic membrane and an enhanced neovas-
cularization indicated by positive immunoreaction with
antibodies against CD 105 (endoglin). By investigating neo-
vascularization histologically and immunohistochemically
we could demonstrate first that newly formed vessels de-
tected by endoglin (CD 105) are predominantly found in
PJI and that endoglin expression allows differentiating be-
tween aseptic loosening and PJI.
As a consequence of the presented results it would be
interesting to establish endoglin as a diagnostic tool for
preoperative differentiation between aseptic loosening and
PJI because tissue samples of the periprosthetic membrane
out of the bone-implant-interface are not accessible with-
out exchange of the prosthesis.
The value of immunohistochemical endoglin detection
has already been demonstrated in the field of tumor diag-
nostics (Dallas et al. 2008). From tumor research we know
that the serum level of endoglin is significantly elevated in
people with metastatic cancer and primary tumors such as
hepatocellular carcinomas (Takahashi et al. 2001; Clasper
et al. 2013; Elnemr et al. 2012). It is focus of current inves-
tigations whether a serum level determination of endoglin
could be used in diagnostics of prosthesis loosening.
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